Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Irritable Bowel Syndrome, March 2021

Free Subscription


Abstracts

Retrieve all available abstracts of the following 96 articles:
HTML format


 

Single Articles

  1. OKUMURA T, Ishioh M, Nozu T
    Central regulatory mechanisms of visceral sensation in response to colonic distension with special reference to brain orexin.
    Neuropeptides. 2021;86:102129.
    PubMed    
    Abstract available

  2. JIANG Y, Song J, Xu Y, Liu C, et al
    Piezo1 regulates intestinal epithelial function by affecting the tight junction protein claudin-1 via the ROCK pathway.
    Life Sci. 2021 Feb 23:119254. doi: 10.1016/j.lfs.2021.119254.
    PubMed    
    Abstract available

  3. FREDERICKS E, Theunissen R, Roux S
    Short chain fatty acids and monocarboxylate transporters in irritable bowel syndrome.
    Turk J Gastroenterol. 2020;31:840-847.
    PubMed    
    Abstract available

  4. YAKLAI K, Pattanakuhar S, Chattipakorn N, Chattipakorn SC, et al
    The Role of Acupuncture on the Gut-Brain-Microbiota Axis in Irritable Bowel Syndrome.
    Am J Chin Med. 2021 Feb 20:1-30. doi: 10.1142/S0192415X21500154.
    PubMed    
    Abstract available

  5. CHANG KM, Lee MH, Lin HH, Wu SL, et al
    Does irritable bowel syndrome increase the risk of interstitial cystitis/bladder pain syndrome? A cohort study of long term follow-up.
    Int Urogynecol J. 2021 Feb 23. pii: 10.1007/s00192-021-04711.
    PubMed    
    Abstract available

  6. AN JR, Jung HS, Seo MS, Kang M, et al
    The effects of tegaserod, a gastrokinetic agent, on voltage-gated K(+) channels in rabbit coronary arterial smooth muscle cells.
    Clin Exp Pharmacol Physiol. 2021 Feb 23. doi: 10.1111/1440-1681.13477.
    PubMed    
    Abstract available

  7. BOHN L, Tornblom H, Van Oudenhove L, Simren M, et al
    A randomized double-blind placebo-controlled crossover pilot study: Acute effects of the enzyme alpha-galactosidase on gastrointestinal symptoms in irritable bowel syndrome patients.
    Neurogastroenterol Motil. 2021 Feb 22:e14094. doi: 10.1111/nmo.14094.
    PubMed    
    Abstract available

  8. FREEMAN K, Taylor-Phillips S, Willis BH, Ryan R, et al
    Test accuracy of faecal calprotectin for inflammatory bowel disease in UK primary care: a retrospective cohort study of the IMRD-UK data.
    BMJ Open. 2021;11:e044177.
    PubMed    
    Abstract available

  9. CIBERT-GOTON V, Lam C, Lingaya M, Falcone Y, et al
    Pain Severity Correlates With Biopsy-Mediated Colonic Afferent Activation But Not Psychological Scores in Patients With IBS-D.
    Clin Transl Gastroenterol. 2021;12:e00313.
    PubMed    
    Abstract available

  10. PATI GK, Kar C, Narayan J, Uthansingh K, et al
    Irritable Bowel Syndrome and the Menstrual Cycle.
    Cureus. 2021;13:e12692.
    PubMed    
    Abstract available

  11. D GOLDENBERG S, Merrick B
    The role of faecal microbiota transplantation: looking beyond Clostridioides difficile infection.
    Ther Adv Infect Dis. 2021;8:2049936120981526.
    PubMed    
    Abstract available

  12. KAZMIERCZAK-SIEDLECKA K, Daca A, Folwarski M, Witkowski JM, et al
    The role of Lactobacillus plantarum 299v in supporting treatment of selected diseases.
    Cent Eur J Immunol. 2020;45:488-493.
    PubMed    
    Abstract available

  13. YANG PL, Burr RL, de la Iglesia HO, Buchanan DT, et al
    Associations between chronotype, social jetlag, and weekday sleep in women with irritable bowel syndrome.
    Chronobiol Int. 2021 Feb 22:1-11. doi: 10.1080/07420528.2021.1885430.
    PubMed    
    Abstract available

  14. WU Y, Murray GK, Byrne EM, Sidorenko J, et al
    GWAS of peptic ulcer disease implicates Helicobacter pylori infection, other gastrointestinal disorders and depression.
    Nat Commun. 2021;12:1146.
    PubMed    
    Abstract available

  15. COUZIN-FRANKEL J
    What causes IBS pain? Maybe immune flare-ups.
    Science. 2021;371:333-334.
    PubMed    


  16. ADAIR T, Belz GT
    When Eating Becomes a Pain in the Gut.
    Trends Immunol. 2021 Mar 2. pii: S1471-4906(21)00047.
    PubMed    
    Abstract available

  17. RIJNAARTS I, Witteman BJM, Zoetendal EG, Govers C, et al
    Subtypes and Severity of Irritable Bowel Syndrome Are Not Related to Patients' Self-Reported Dietary Triggers: Results From an Online Survey in Dutch Adults.
    J Acad Nutr Diet. 2021 Mar 2. pii: S2212-2672(21)00028.
    PubMed    
    Abstract available

  18. SIPAVICIUTE A, Aukstikalnis T, Samalavicius NE, Dulskas A, et al
    The Role of Traditional Acupuncture in Patients with Fecal Incontinence-Mini-Review.
    Int J Environ Res Public Health. 2021;18.
    PubMed    
    Abstract available

  19. SANCHEZ-VARGAS LA, Hernandez-Flores KG, Cabrera-Jorge FJ, Remes-Troche JM, et al
    The Prevalence of Anti-Zein Antibodies: A Comparative Study between Celiac Disease and Irritable Bowel Syndrome.
    Nutrients. 2021;13.
    PubMed    
    Abstract available

  20. GHEBRETATIOS M, Schaly S, Prakash S
    Nanoparticles in the Food Industry and Their Impact on Human Gut Microbiome and Diseases.
    Int J Mol Sci. 2021;22.
    PubMed    
    Abstract available

  21. LEAKE HB, Moseley GL, Stanton TR, Heathcote LC, et al
    Using Mediation Analysis to Understand How Treatments for Paediatric Pain Work: A Systematic Review and Recommendations for Future Research.
    Children (Basel). 2021;8.
    PubMed    
    Abstract available

  22. EOM S, Jung W, Lee J, Yeom HD, et al
    Differential Regulation of Human Serotonin Receptor Type 3A by Chanoclavine and Ergonovine.
    Molecules. 2021;26.
    PubMed    
    Abstract available

  23. MEI L, Zhou J, Su Y, Mao K, et al
    Gut microbiota composition and functional prediction in diarrhea-predominant irritable bowel syndrome.
    BMC Gastroenterol. 2021;21:105.
    PubMed    
    Abstract available

  24. LI H, Chen Y, Hu Z, Jiang J, et al
    Effectiveness of acupuncture for anxiety and depression in irritable bowel syndrome: A protocol for systematic review and meta-analysis.
    Medicine (Baltimore). 2021;100:e24958.
    PubMed    
    Abstract available

  25. CHEN M, Qin D, Huang SL, Tang TC, et al
    Chinese herbal medicine versus antispasmodics in the treatment of irritable bowel syndrome: A network meta-analysis.
    Neurogastroenterol Motil. 2021 Mar 4:e14107. doi: 10.1111/nmo.14107.
    PubMed    
    Abstract available

  26. JANDEE S, Chuensakul S, Maneerat S
    No distinction in the gut microbiota between diarrhea predominant-irritable bowel syndrome and healthy subjects: matched case-control study in Thailand.
    Gut Pathog. 2021;13:16.
    PubMed    
    Abstract available

  27. LI ZS, Hung LY, Margolis KG, Ambron RT, et al
    The alpha isoform of cGMP-dependent protein kinase 1 (PKG1alpha) is expressed and functionally important in intrinsic primary afferent neurons of the guinea pig enteric nervous system.
    Neurogastroenterol Motil. 2021 Mar 3:e14100. doi: 10.1111/nmo.14100.
    PubMed    
    Abstract available

  28. RICHARDS NE, Richards RD Jr
    Alpha-Gal Allergy as a Cause of Intestinal Symptoms in a Gastroenterology Community Practice.
    South Med J. 2021;114:169-173.
    PubMed    
    Abstract available

  29. MENEZES LAA, De Marco I, Neves Oliveira Dos Santos N, Costa Nunes C, et al
    Reducing FODMAPs and improving bread quality using type II sourdough with selected starter cultures.
    Int J Food Sci Nutr. 2021 Mar 2:1-11. doi: 10.1080/09637486.2021.1892603.
    PubMed    
    Abstract available

  30. SKRZYDLO-RADOMANSKA B, Prozorow-Krol B, Cichoz-Lach H, Majsiak E, et al
    The Effectiveness and Safety of Multi-Strain Probiotic Preparation in Patients with Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized Controlled Study.
    Nutrients. 2021;13.
    PubMed    
    Abstract available

  31. RAFFERTY AJ, Hall R, Johnston CS
    A Novel Mobile App (Heali) for Disease Treatment in Participants With Irritable Bowel Syndrome: Randomized Controlled Pilot Trial.
    J Med Internet Res. 2021;23:e24134.
    PubMed    
    Abstract available

  32. MERTSALMI TH, But A, Pekkonen E, Scheperjans F, et al
    Irritable Bowel Syndrome and Risk of Parkinson's Disease in Finland: A Nationwide Registry-Based Cohort Study.
    J Parkinsons Dis. 2021 Feb 23. pii: JPD202330. doi: 10.3233/JPD-202330.
    PubMed    
    Abstract available

  33. LIU YY, Mu FY, Wang YC, Wang MY, et al
    [Effect of Valeriana jatamansi extract on fecal UPLC-MS/MS metabolomics in rats with diarrheal irritable bowel syndrome].
    Zhongguo Zhong Yao Za Zhi. 2021;46:678-684.
    PubMed    
    Abstract available

  34. ANDREWS CN, Sidani S, Marshall JK
    Clinical Management of the Microbiome in Irritable Bowel Syndrome.
    J Can Assoc Gastroenterol. 2020;4:36-43.
    PubMed    
    Abstract available

  35. HUSIC R, Lackner A, Kump PK, Hogenauer C, et al
    High Prevalence of Ultrasound Verified Enthesitis in Patients With Inflammatory Bowel Disease With or Without Spondylarthritis.
    Front Med (Lausanne). 2021;8:637459.
    PubMed    
    Abstract available

  36. ANTHEA P, Tiziana F, Francesca P, Pierre E, et al
    Prevalence, Behaviours and Burden of Irritable Bowel Syndrome in Medical Students and Junior Doctors.
    Ulster Med J. 2021;90:16-21.
    PubMed    
    Abstract available

  37. RAI RR, Nijhawan S
    Comparative evaluation of efficacy and safety of drotaverine versus mebeverine in irritable bowel syndrome: A randomized double-blind controlled study.
    Saudi J Gastroenterol. 2021 Feb 24. pii: 310118. doi: 10.4103.
    PubMed    
    Abstract available

  38. MARTINEZ-ISLAS BR, Medel-Flores O, Perez Soto E, Garcia-Vivas JM, et al
    Evaluation of Individualized Homeopathic Treatment in Patients With Irritable Bowel Syndrome: A Pilot Study.
    Altern Ther Health Med. 2021 Mar 13. pii: AT6318.
    PubMed    
    Abstract available

  39. CHEN J, Li Q, Saliuk G, Bazhanov S, et al
    Estrogen and serotonin enhance stress-induced visceral hypersensitivity in female rats by up-regulating brain-derived neurotrophic factor in spinal cord.
    Neurogastroenterol Motil. 2021 Mar 11:e14117. doi: 10.1111/nmo.14117.
    PubMed    
    Abstract available

  40. WEN Y, Jiang MZ
    [Role of vitamin D in pediatric irritable bowel syndrome].
    Zhongguo Dang Dai Er Ke Za Zhi. 2021;23:310-314.
    PubMed    
    Abstract available

  41. MAROTI D, Ek J, Widlund RM, Schubiner H, et al
    Internet-Administered Emotional Awareness and Expression Therapy for Somatic Symptom Disorder With Centralized Symptoms: A Preliminary Efficacy Trial.
    Front Psychiatry. 2021;12:620359.
    PubMed    
    Abstract available

  42. COLOMIER E, Algera J, Melchior C
    Pharmacological Therapies and Their Clinical Targets in Irritable Bowel Syndrome With Diarrhea.
    Front Pharmacol. 2021;11:629026.
    PubMed    
    Abstract available

  43. ZHANG Y, Feng L, Wang X, Fox M, et al
    Low fermentable oligosaccharides, disaccharides, monosaccharides, and polyols diet compared with traditional dietary advice for diarrhea-predominant irritable bowel syndrome: a parallel-group, randomized controlled trial with analysis of clinical and
    Am J Clin Nutr. 2021 Mar 19. pii: 6178924. doi: 10.1093.
    PubMed    
    Abstract available

  44. ALONSO-COTONER C, Abril-Gil M, Albert-Bayo M, Mall JG, et al
    The Role of Purported Mucoprotectants in Dealing with Irritable Bowel Syndrome, Functional Diarrhea, and Other Chronic Diarrheal Disorders in Adults.
    Adv Ther. 2021 Mar 18. pii: 10.1007/s12325-021-01676.
    PubMed    
    Abstract available

  45. TALAVERA JIR, Parrill AM, Elsayad C, Fogel J, et al
    The association between ectopic pregnancy and inflammatory bowel disease, irritable bowel syndrome, and celiac disease: A systematic review.
    J Obstet Gynaecol Res. 2021 Mar 17. doi: 10.1111/jog.14705.
    PubMed    
    Abstract available

  46. BAALEMAN DF, Velasco-Benitez CA, Mendez-Guzman LM, Benninga MA, et al
    Functional gastrointestinal disorders in children: agreement between Rome III and Rome IV diagnoses.
    Eur J Pediatr. 2021 Mar 18. pii: 10.1007/s00431-021-04013.
    PubMed    
    Abstract available

  47. MAHBOUBI M
    Mentha spicata L. essential oil, phytochemistry and its effectiveness in flatulence.
    J Tradit Complement Med. 2018;11:75-81.
    PubMed    
    Abstract available

  48. HANNA MH, Kaiser AM
    Update on the management of sigmoid diverticulitis.
    World J Gastroenterol. 2021;27:760-781.
    PubMed    
    Abstract available

  49. JIANG J, Chen Y, Hu Z, Li H, et al
    Effectiveness of Tong-Xie-Yao-Fang combined with Si-Ni-San for irritable bowel syndrome: A protocol for systematic review and meta-analysis.
    Medicine (Baltimore). 2021;100:e25198.
    PubMed    
    Abstract available

  50. ZHANG Y, Liu R, Wang J, Yan S, et al
    To assess the effective and safety of compound glutamine entersoluble capsules in irritable bowel syndrome: A protocol for systematic review and meta-analysis.
    Medicine (Baltimore). 2021;100:e25098.
    PubMed    
    Abstract available

  51. LEE J, Sung WS, Kim EJ, Kim YW, et al
    Xiaoyao-san, a traditional Chinese herbal formula, for the treatment of irritable bowel syndrome: A protocol for a systematic review and meta-analysis.
    Medicine (Baltimore). 2021;100:e24019.
    PubMed    
    Abstract available

  52. SIMPSON CA, Schwartz OS, Eliby D, Butler CA, et al
    Bugs and Brains, the Gut and Mental Health Study: a mixed-methods study investigating microbiota composition and function in anxiety, depression and irritable bowel syndrome.
    BMJ Open. 2021;11:e043221.
    PubMed    
    Abstract available

  53. KUCHERYAVYY YA, Andreev DN, Maev IV
    [Prevalence of small bowel bacterial overgrowth in patients with functional dyspepsia: a meta-analysis].
    Ter Arkh. 2020;92:53-58.
    PubMed    
    Abstract available

  54. SHIHA MG, Asghar Z, Thoufeeq M, Kurien M, et al
    Increased psychological distress and somatization in patients with irritable bowel syndrome compared with functional diarrhea or functional constipation, based on Rome IV criteria.
    Neurogastroenterol Motil. 2021 Mar 14:e14121. doi: 10.1111/nmo.14121.
    PubMed    
    Abstract available

  55. HANNING N, Edwinson AL, Ceuleers H, Peters SA, et al
    Intestinal barrier dysfunction in irritable bowel syndrome: a systematic review.
    Therap Adv Gastroenterol. 2021;14:1756284821993586.
    PubMed    
    Abstract available

  56. CRISTOFORI F, Dargenio VN, Dargenio C, Miniello VL, et al
    Anti-Inflammatory and Immunomodulatory Effects of Probiotics in Gut Inflammation: A Door to the Body.
    Front Immunol. 2021;12:578386.
    PubMed    
    Abstract available

  57. CHOJNACKI C, Mikulska P, Knopik-DAbrowicz A, Kaczka A, et al
    [The role of intraepithelial lymphocytes in pathogenesis of small intestinal bacterial overgrowth syndrome].
    Pol Merkur Lekarski. 2021;49:23-27.
    PubMed    
    Abstract available

  58. VINCENT K, Evans E
    An update on the management of chronic pelvic pain in women.
    Anaesthesia. 2021;76 Suppl 4:96-107.
    PubMed    
    Abstract available

  59. DE BRUIJN CMA, Rexwinkel R, Gordon M, Benninga M, et al
    Antidepressants for functional abdominal pain disorders in children and adolescents.
    Cochrane Database Syst Rev. 2021;2:CD008013.
    PubMed    
    Abstract available

  60. BRONSWIJK M, Ieven T, Schrijvers R, Vermeire S, et al
    Membranous colitis: a potentially bone-deep diagnosis.
    Acta Gastroenterol Belg. 2020;83:674.
    PubMed    


  61. GILL SK, Rossi M, Bajka B, Whelan K, et al
    Dietary fibre in gastrointestinal health and disease.
    Nat Rev Gastroenterol Hepatol. 2021;18:101-116.
    PubMed    
    Abstract available

  62. HOLLAND AM, Bon-Frauches AC, Keszthelyi D, Melotte V, et al
    The enteric nervous system in gastrointestinal disease etiology.
    Cell Mol Life Sci. 2021 Mar 26. pii: 10.1007/s00018-021-03812.
    PubMed    
    Abstract available

  63. BRENNER DM, Sayuk GS, Abel JL, Burslem K, et al
    Improved work productivity and health-related quality of life in patients with irritable bowel syndrome with diarrhea receiving eluxadoline following inadequate response to loperamide.
    J Manag Care Spec Pharm. 2021;27:469-477.
    PubMed    
    Abstract available

  64. LIM J, Park H, Lee H, Lee E, et al
    Higher frailty burden in older adults with chronic constipation.
    BMC Gastroenterol. 2021;21:137.
    PubMed    
    Abstract available

  65. MOON CM, Hong SN
    Fecal Microbiota Transplantation after Clostridioides Difficile Infection.
    Clin Endosc. 2021 Mar 26. pii: ce.2021.068. doi: 10.5946/ce.2021.
    PubMed    
    Abstract available

  66. BOSMAN M, Elsenbruch S, Corsetti M, Tack J, et al
    The placebo response rate in pharmacological trials in patients with irritable bowel syndrome: a systematic review and meta-analysis.
    Lancet Gastroenterol Hepatol. 2021 Mar 22. pii: S2468-1253(21)00023.
    PubMed    
    Abstract available

  67. SHAH ED
    Optimising clinical trial design to manage placebo response in randomised controlled trials of irritable bowel syndrome.
    Lancet Gastroenterol Hepatol. 2021 Mar 22. pii: S2468-1253(21)00056.
    PubMed    


  68. YOON K, Kim N
    Roles of Sex Hormones and Gender in the Gut Microbiota.
    J Neurogastroenterol Motil. 2021 Mar 25. pii: jnm20208. doi: 10.5056/jnm20208.
    PubMed    
    Abstract available

  69. HINER GE, Walters JR
    A practical approach to the patient with chronic diarrhoea.
    Clin Med (Lond). 2021;21:124-126.
    PubMed    
    Abstract available

  70. PRAKASH S, Prakash A
    Dopa responsive irritable bowel syndrome: restless bowel syndrome or a gastrointestinal variant of restless legs syndrome?
    BMJ Case Rep. 2021;14.
    PubMed    
    Abstract available

  71. YIN S, Sun C, Ji Y, Abdolmaleky H, et al
    Herbal medicine WangShiBaoChiWan improves gastrointestinal health in mice via modulation of intestinal tight junctions and gut microbiota and inhibition of inflammation.
    Biomed Pharmacother. 2021 Mar 21:111426. doi: 10.1016/j.biopha.2021.111426.
    PubMed    
    Abstract available

  72. SEAMARK L, Barclay Y, Marchant C, Williams M, et al
    Long-term symptom severity in people with irritable bowel syndrome following dietetic treatment in primary care: A service evaluation.
    J Hum Nutr Diet. 2021 Mar 24. doi: 10.1111/jhn.12860.
    PubMed    
    Abstract available

  73. XIAO Y, Xie L, Xu QY, Chen L, et al
    Transcranial direct current stimulation relieves visceral hypersensitivity via normalizing GluN2B expression and neural activity in anterior cingulate corter.
    J Neurophysiol. 2021 Mar 24. doi: 10.1152/jn.00025.2021.
    PubMed    
    Abstract available

  74. VAN KESSEL L, Teunissen D, Lagro-Janssen T
    Sex-Gender Differences in the Effectiveness of Treatment of Irritable Bowel Syndrome: A Systematic Review.
    Int J Gen Med. 2021;14:867-884.
    PubMed    
    Abstract available

  75. MOSHIREE B, Rao S
    Up-to-Date Diagnosis and Management of IBS and Chronic Constipation in Primary Care.
    J Fam Pract. 2021;70.
    PubMed    
    Abstract available

  76. ZHOU WC, Jia L, Deng Q, Wen YG, et al
    Role of serum amitriptyline concentration and CYP2C19 polymorphism in predicting the response to low-dose amitriptyline in irritable bowel syndrome.
    Dig Liver Dis. 2021 Mar 19. pii: S1590-8658(21)00089.
    PubMed    
    Abstract available

  77. POLSTER A, Ohman L, Tap J, Derrien M, et al
    A novel stepwise integrative analysis pipeline reveals distinct microbiota-host interactions and link to symptoms in irritable bowel syndrome.
    Sci Rep. 2021;11:5521.
    PubMed    
    Abstract available

  78. STENGEL A, Gourcerol G, Tache Y
    Editorial: Neurogastroenterology - Focus on the Gut-Brain Axis.
    Front Psychiatry. 2021;12:653910.
    PubMed    


  79. DI PIERRO F, Pane M
    Bifidobacterium longum W11: Uniqueness and individual or combined clinical use in association with rifaximin.
    Clin Nutr ESPEN. 2021;42:15-21.
    PubMed    
    Abstract available

  80. OWUSU JT, Sibelli A, Moss-Morris R, van Tilburg MAL, et al
    A pilot feasibility study of an unguided, internet-delivered cognitive behavioral therapy program for irritable bowel syndrome.
    Neurogastroenterol Motil. 2021 Mar 21:e14108. doi: 10.1111/nmo.14108.
    PubMed    
    Abstract available

  81. BLACK CJ, Yiannakou Y, Guthrie E, West R, et al
    Longitudinal follow-up of a novel classification system for irritable bowel syndrome: natural history and prognostic value.
    Aliment Pharmacol Ther. 2021 Mar 11. doi: 10.1111/apt.16322.
    PubMed    
    Abstract available

  82. PLASSE TF
    Reply to Black and Ford.
    Am J Gastroenterol. 2021;116:429.
    PubMed    


  83. BUSHYHEAD DW
    Continuing Medical Education Questions: March 2021: Irritable Bowel Syndrome in.
    Am J Gastroenterol. 2021;116:456.
    PubMed    
    Abstract available

  84. SABO CM, Grad S, Dumitrascu DL
    Chronic abdominal pain in general practice.
    Dig Dis. 2021 Feb 25. pii: 000515433. doi: 10.1159/000515433.
    PubMed    
    Abstract available

  85. COMPARE D, Sgamato C, Nardone OM, Rocco A, et al
    PROBIOTICS IN GASTROINTESTINAL DISEASES: ALL THAT GLITTERS IS NOT GOLD.
    Dig Dis. 2021 Mar 22. pii: 000516023. doi: 10.1159/000516023.
    PubMed    
    Abstract available

  86. NAKOV R, Snegarova V, Dimitrova-Yurukova D, Velikova T, et al
    Biomarkers in Irritable Bowel Syndrome: biological rationale and diagnostic value.
    Dig Dis. 2021 Mar 22. pii: 000516027. doi: 10.1159/000516027.
    PubMed    
    Abstract available

  87. MAHURKAR-JOSHI S, Rankin CR, Videlock EJ, Soroosh A, et al
    The Colonic Mucosal MicroRNAs, MicroRNA-219a-5p and MicroRNA-338-3p, are Downregulated in Irritable Bowel Syndrome and are Associated with Barrier Function and MAPK signaling.
    Gastroenterology. 2021 Feb 19. pii: S0016-5085(21)00430.
    PubMed    
    Abstract available

  88. HASAN SS, Whorwell PJ, Miller V, Morris J, et al
    Six versus twelve sessions of gut-focused hypnotherapy for irritable bowel syndrome: a randomized trial.
    Gastroenterology. 2021 Mar 1. pii: S0016-5085(21)00463.
    PubMed    


  89. WEERTS ZZRM, Masclee AAM, Jonkers DMAE, Keszthelyi D, et al
    Reply.
    Gastroenterology. 2020;159:396-397.
    PubMed    


  90. UNO Y
    Why a Low FODMAP Diet Was Ineffective for IBS Symptoms in Quiescent Crohn's Disease.
    Gastroenterology. 2020;159:399.
    PubMed    


  91. EL-SALHY M, Patcharatrakul T, Gonlachanvit S
    The role of diet in the pathophysiology and management of irritable bowel syndrome.
    Indian J Gastroenterol. 2021 Mar 5. pii: 10.1007/s12664-020-01144.
    PubMed    
    Abstract available

  92. ROUDI F, Khayyatzadeh SS, Ghazizadeh H, Ferns GA, et al
    The relationship between dietary intakes and prevalence of irritable bowel syndrome in adolescent girls: A cross-sectional study.
    Indian J Gastroenterol. 2021 Mar 5. pii: 10.1007/s12664-020-01126.
    PubMed    
    Abstract available

  93. NAM K, Kim N, Song HJ, Baik GH, et al
    Gender difference in the overlap of irritable bowel syndrome and functional dyspepsia: a prospective nationwide multicenter study in Korea.
    J Gastroenterol. 2021 Mar 9. pii: 10.1007/s00535-021-01775.
    PubMed    
    Abstract available

  94. QUEK SXZ, Loo EXL, Demutska A, Chua CE, et al
    The Impact of the Coronavirus Disease 2019 (COVID-19) pandemic on Irritable Bowel Syndrome.
    J Gastroenterol Hepatol. 2021 Feb 21. doi: 10.1111/jgh.15466.
    PubMed    
    Abstract available

  95. CAMILLERI M
    Diagnosis and Treatment of Irritable Bowel Syndrome: A Review.
    JAMA. 2021;325:865-877.
    PubMed    
    Abstract available

  96. JAKOBSEN MD, Obstfelder A, Braaten T, Abelsen B, et al
    The self-management work of food hypersensitivity.
    PLoS One. 2021;16:e0248181.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Irritable Bowel Syndrome is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;